Skip To Main Content

Science at Sanofi

Discover a wide variety of articles, videos, podcasts, accredited courses, applications, conferences and scientific events in different therapeutic areas.

Sort by

Filters

Reset
  • Therapeutical Areas
  • Type of Content

EoE Pathophysiology

VESTIGE Trial Results: Dupilumab in Type 2 Asthma

This video presents results from the Phase 4 VESTIGE trial, demonstrating how dupilumab improves airway structure and function in severe type 2 asthma. Using breakthrough Functional Respiratory Imaging technology, the study reveals structural improvements that conventional lung function tests may not detect.

New horizon of RSV lower respiratory tract disease LRTD in infants: Reflection on two seasons of prevention

Loss of Smell Improvement in Patients With CRSwNP

Infectious Disease During Mass Gathering

Type 2 Inflammation in the Pathophysiology of the Lower Airways

Beyond High-Risk: Expanding RSV Protection for Newborns and Infants

VESTIGE study

Mucus Plugging Is a Key Component of Remodeling
in Asthma, Leading to Fixed Airway Obstruction

Loss of Smell Is a Key Symptom in CRSwNP

Every Moment Matters: Navigating Diagnosis of Fabry Disease

Pediatric Asthma FeNO